Vitolo Ottavio V. 4
4 · RELMADA THERAPEUTICS, INC. · Filed Dec 20, 2018
Insider Transaction Report
Form 4
Vitolo Ottavio V.
Chief Medical Officer
Transactions
- Award
Options to purchase common stock
2018-12-20$1.15/sh+400,000$460,000→ 400,000 totalExercise: $1.15Exp: 2028-12-20→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant.